All Regulatory Rapporteur articles in RegRepPlus 2024 – Page 2
-
Industry newsRadio waves used to hijack E.coli bacteria to make medicines
Researchers have developed a method that uses high-frequency radio waves to temporarily open bacterial cell walls to introduce new DNA.
-
Industry newsSponge-on-a-string cuts wait time for Barrett’s diagnosis
A procedure to test for a precancerous condition of the oesophagus, which uses a novel medical device, is under trial in NHS England.
-
Industry newsMHRA reclassifies codeine linctus as prescription-only
Over-the-counter cough syrups which contain the opioid codeine have been reclassified as prescription-only medicines due to the risk of abuse.
-
Industry newsViolin resin works as cleaning agent for ‘superbugs’
A form of resin taken from a Norway spruce has been found to also function as an effective disinfectant against drug-resistant bacteria.
-
Industry newsAngioedemas caused by rare gene fault curable by CRISPR
A single dose of a CRISPR gene therapy has been shown to almost eliminate a rare genetic, inflammatory and potentially life-threatening condition.
-
CommentaryCell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession
Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession
-
Industry newsEMA platform to monitor use of antimicrobials
All EU member states are required to submit data on sales and use of antimicrobials in animals to the EMA’s new platform.
-
Industry newsNHS Pharmacy First offers an alternative to GPs in England
Pharmacists in England can now provide treatment for seven common health conditions without patients first consulting a doctor.
-
CommentaryDeveloping a digital people strategy to harness the power of generative AI
Artificial intelligence is a science and applied technology that involves deductive processing and machine learning subsequently performing human-like tasks
-
Industry newsAUS-UK joint agency vetmed approval process agreed
The UK’s VMD and Australia’s APVMA have published guidance for the simultaneous review of veterinary medicines submissions.
-
Industry newsDisposable vapes set to be banned in Britain by 2025
UK Prime Minister Rishi Sunak has announced a ban on disposable vapes, expected to be enforced in England, Wales and Scotland from 2025.
-
Industry news£34m NIHR funding open to researchers from LMICs and UK
The NIHR has announced a new award to help create career opportunities for researchers from low-and middle-income countries and the UK.
-
Industry newsNon-surgical gastric balloon to be made available on NHS
A novel gastric ‘balloon’ medical device has been made available on the UK’s National Health Service (NHS) for the first time.
-
Industry newsMHRA tightens restrictions on fluoroquinolones
The UK’s MHRA has announced that fluoroquinolone antibiotics can only be prescribed when no other antibiotic is appropriate.
-
Industry newsDevice which can detect skin cancer approved by FDA
The FDA has approved a wireless hand-held device that uses an artificial intelligence-powered algorithm to detect skin cancer.
-
Industry newsScientists hail gram-negative-bacteria killing antibiotic
A novel class of antibiotic has been discovered that is effective against the extensive drug-resistant, gram-negative bacteria, Crab.
-
Industry newsMHRA workplan to support safe access to medtech
The MHRA has published a two-year workplan which will see the introduction of a range of new regulations for medical devices in the UK.
-
Industry newsEMA set to host psychedelics uses workshop in April
The EMA will host a workshop to discuss the therapeutic potential of psychedelic substances to address unmet medical need.
-
Industry news3D-printed device could reduce need for animal testing
A 3D-printed device is able to determine the effects of drugs on the human body and could help reduce the need for testing drugs in animals.
-
Industry newsNon-hormonal menopause drug approved in UK
The MHRA has authorised a non-hormonal medicine, Veoza, which targets a protein in the brain to stop vasomotor symptoms in menopause.
- Previous Page
- Page1
- Page2
- Page3
- Next Page